Exenatide significantly improved 24-hour average glucose compared to sitagliptin in patients with type 2 diabetes

被引：0
|
作者：
Shenouda, S. K. [1 ]
Holcombe, J. H. [2 ]
Heilmann, C. R.
机构：
[1] Eli Lilly & Co, Global Med Commun, Indianapolis, IN 46285 USA
[2] Lilly USA LLC, Indianapolis, IN USA
来源：
DIABETOLOGIA | 2010年 / 53卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
831
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Exenatide Resulted in Significantly Greater Improvements in 24h Average Glucose Compared to Sitagliptin in Patients with Type 2 Diabetes
    Holcombe, John H.
    Shenouda, Sylvia K.
    Heilmann, Cory R.
    DIABETES, 2010, 59 : A184 - A184
  • [2] Effects of exenatide and liraglutide on 24-hour glucose fluctuations in type 2 diabetes
    Nagakura, Jo
    Yamakawa, Tadashi
    Taguri, Masataka
    Tsuchiya, Hirohisa
    Shigematsu, Erina
    Suzuki, Jun
    Morita, Satoshi
    Kadonosono, Kazuaki
    Terauchi, Yasuo
    ENDOCRINE JOURNAL, 2016, 63 (03) : 239 - 247
  • [3] Modeling of 24-Hour Glucose and Insulin Profiles of Patients With Type 2 Diabetes
    Jauslin, Petra M.
    Frey, Nicolas
    Karlsson, Mats O.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 51 (02): : 153 - 164
  • [4] Effect of Sitagliptin on 24-Hour Glycemic Variations in Japanese Patients with Type 2 Diabetes as Assessed by Continuous Glucose Monitoring (CGM)
    Taniguchi, Yukiko
    Mori, Yutaka
    Matsuura, Kenichi
    Itoh, Yohta
    Sezaki, Kazunori
    Yokoyama, Junichi
    Tajima, Naoko
    DIABETES, 2010, 59 : A558 - A558
  • [5] Improved 24-hour plasma glucose profile in patients with type 2 diabetes treated with Humalog® Mix25™
    Herz, M
    Arora, V
    Mollentze, W
    DIABETES, 2001, 50 : A117 - A117
  • [6] Mean 24-hour glucose and postprandial glucose are lower with insulin lispro mixture 75/25 compared with insulin glargine in patients with type 2 diabetes
    Roach, P
    Malone, JK
    DIABETES, 2005, 54 : A134 - A134
  • [7] Mean postprandial and 24-hour glucose are lower with insulin lispro mixture 25/75 compared with insulin glargine in patients with type 2 diabetes mellitus
    Malone, JK
    Roach, P
    DIABETOLOGIA, 2005, 48 : A301 - A302
  • [8] Exenatide once weekly improved 24-hour glucose control and reduced glycaemic variability in metformin-treated participants with type 2 diabetes: a randomized, placebo-controlled trial
    Frias, Juan P.
    Nakhle, Samer
    Ruggles, James A.
    Zhuplatov, Sergey
    Klein, Eric
    Zhou, Rong
    Strange, Poul
    DIABETES OBESITY & METABOLISM, 2017, 19 (01): : 40 - 48
  • [9] Modeling of 24-hour glucose and insulin profiles in patients with type 2 diabetes mellitus treated with biphasic insulin aspart
    Roge, Rikke M.
    Klim, Soren
    Kristensen, Niels R.
    Ingwersen, Steen H.
    Kjellsson, Maria C.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2014, 54 (07): : 809 - 817
  • [10] Effects of dapagliflozin (DAPA), a sodium glucose cotransporter 2 inhibitor, on 24-hour glycaemic control in patients with type 2 diabetes
    Mansfield, T.
    Henry, R. R.
    Strange, P.
    Zhou, R.
    Zhuplatov, S. B.
    Klein, D.
    Katz, A.
    DIABETOLOGIA, 2016, 59 : S339 - S339
12345